News from glenmark pharmaceuticals ltd

Jul 03, 2014, 09:04 ET
Glenmark Pharmaceuticals Ltd Logo

Glenmark's Novel Monoclonal Antibody GBR 830 for Treatment of Autoimmune Diseases Entering Human Trials

  - GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of autoimmune diseases targeting...

Jul 02, 2014, 09:50 ET
Glenmark sets new Guinness World RecordsTM by creating globe’s largest mosaic of pet bottles in shape of a smiley

Doctors' Role Commemorated on Doctor's Day by Creating World's Largest Pet Bottle Mosaic in the Shape of a Smile at JJ Hospital, Mumbai

~All the expectorant pet bottles used in creating this smiley are to be donated to 32 Government Hospitals across the country to provide relief...

Jun 04, 2014, 05:51 ET
PR NEWSWIRE INDIA - Glenmark Pharmaceuticals S.A, Switzerland

Glenmark Pharmaceuticals Inaugurates New Antibody Manufacturing Facility in La Chaux-de-Fonds, Switzerland

- State-of-the-art Manufacturing Facility for Supply of Clinical Trial Material    - With the Facility Glenmark has end-to-end...

Apr 29, 2014, 07:23 ET

Glenmark's novel monoclonal antibody GBR 900 for treatment of chronic pain entering human trials

- GBR 900 is a first in class monoclonal antibody for the treatment of chronic pain targeting TrkA, the receptor of nerve growth factor...

Apr 03, 2014, 09:28 ET
Glenmark Pharmaceuticals Ltd Logo

Glenmark's Novel Molecule 'GRC 27864' for Chronic Inflammatory Diseases Including Pain Entering Human Trials

  - GRC 27864 is a potent, selective, orally bioavailable inhibitor of mPGES-1 - The molecule has successfully completed...

Dec 23, 2013, 08:03 ET
L to R – Dr. Ashwini Gandhi (Vice President, FOGSI), Dr. Aparna Hegde (Founder, Chairperson and Managing Trustee, ARMMAN), Mr. Jayant Banthia (Ex-Chief Secretary of Government of Maharashtra), Ms. Cheryl Pinto (Director, Corporate Affairs Glenmark), Dr. Mamta Manglani (HOD, Dept. of Paediatrics, LTMGH)

mMitra, a Free Voice Messaging Health Advisory Service Launched for Pregnant Women & Mothers at Sion Hospital, Mumbai

First of its kind public-private partnership between an NGO, Corporate and Government Institution, coming together for a social cause mMitra, a...

Dec 02, 2013, 02:55 ET
Glenmark Pharmaceuticals Ltd Logo

Glenmark Announces Appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API Business

Glenmark Pharmaceuticals announces the appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API business. Phil has...

Oct 31, 2013, 10:08 ET
Glenmark Pharmaceuticals Ltd Logo

Glenmark's Consolidated Revenue Increases by 16.56% to Rs. 14630.06 Mn for Q2 FY 13-14

Net Profit for the second quarter was Rs 1542.97 Mn as compared to Rs. 1567.52 mn for the previous corresponding...

Oct 29, 2013, 05:17 ET
EDGE CME in Dubai, Oct 11, 2013: Key Note Speakers, Panellists along with Organisers & Sponsors: (L to R) - Mr. Sujesh Vasudevan (Glenmark), Mr. Khalid El-Biecy (Glenmark) , Dr. Rishi Jain (Glenmark), Dr. Salah Al Azawi (Sharjah), Dr. Hanish Babu (UAE), Dr  Anwar Al Hammadi (Dubai), Prof Lynn McKinley-Grant (Washington, DC, USA), Dr. Samir Al-Ali (Abu Dhabi), Prof Vidya Kharkar (Mumbai, India), Prof Tariq Mughal (Boston, Massachusetts, USA), Mr. Rajesh Ramadurai (Glenmark)

'EDGE' - An Internationally Accredited Innovative Dermatology CME Program Held in United Arab Emirates and the Sultanate of Oman on 11th - 12th October, 2013

'EDGE (Excellence in Dermatology a Global InitiativE)' an internationally accredited continuing medical education (CME) program for...

Jul 24, 2013, 08:00 ET
Glenmark Pharmaceuticals Ltd Logo

Glenmark Pharmaceuticals annonce le lancement de son programme RSE pour la Santé infantile au Kenya

Glenmark, la principale compagnie pharmaceutique internationale intégrée et axée sur la recherche, a annoncé le lancement de...

Jul 23, 2013, 10:24 ET
Community Health worker in Kibera area of Nairobi, measuring nutrition grade for child

Glenmark Pharmaceuticals Announces Launch of its Child Health CSR Programme in Kenya

Glenmark, the leading research-driven, global, integrated pharmaceutical company has announced the launch of its Child Health Corporate...

Jun 26, 2013, 03:03 ET
Glenmark Pharmaceuticals Ltd Logo

Glenmark Foundation' Announces Positive Impact of its Child Health Programme in Madhya Pradesh Focused on the Marginalized Korku Tribe

Shri Mahendra Hardia, Honorable Health Minister, Madhya Pradesh graces the occasion along with other dignitaries from the State...

Feb 04, 2013, 06:08 ET

Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40

- GBR 830 is the first antagonistic antibody targeting OX40 and is a potential Global First-in-class molecule - OX40, also known as...

Feb 04, 2013, 06:08 ET

Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40

- GBR 830 is the first antagonistic antibody targeting OX40 and is a potential Global First-in-class molecule - OX40, also known as...

Feb 04, 2013, 05:09 ET

Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40

- GBR 830 is the First Antagonistic Antibody Targeting OX40 and is a Potential Global First-in-class Molecule - OX40, Also Known as CD134, Plays...

Jan 29, 2013, 23:43 ET

Glenmark's Consolidated Revenue Increases by 33.96% to Rs. 13812.59 Million for Q3 FY 12-13

Net Profit for the Third Quarter was Rs. 2129.17 Mn as Compared to Rs. 448.24 Mn for the Previous Corresponding Quarter Highlights: Q3-FY13 -...

Jan 02, 2013, 04:43 ET

USFDA Approves Crofelemer 125 mg Delayed-release Tablets for the Symptomatic Relief of Diarrhea in Patients With HIV/AIDS on Anti-Retroviral Therapy (ART)

This Will be the First NCE (New Chemical Entity) Launch by an Indian Company Across Multiple Geographies Glenmark Pharmaceuticals Limited...

Dec 11, 2012, 02:00 ET

M. Glenn Saldanha, président du conseil d'administration et PDG de Glenmark Pharma reçoit le Prix de l'ambassadeur pour innovation exceptionnelle

~ Le travail exceptionnel accompli par les chercheurs de Glenmark dans son nouveau centre de recherche et développement biologique, à...

Dec 11, 2012, 02:00 ET

Vorsitzender & Managing Director von Glenmark Pharma - Herr Glenn Saldanha - erhielt Preis des Schweizer Botschafters für außergewöhnliche Innovation

~Die außergewöhnliche Arbeit der Wissenschaftler von Glenmarks neuen F&E-Zentrum für Biologika in Neuchâtel (Schweiz)...

Nov 30, 2012, 04:25 ET

Mr. Glenn Saldanha Honoured With 'Swiss Ambassador's Award for Exceptional Innovation'

Mr. Glenn Saldanha Becomes the Third Recipient of This Prestigious Award After Mr. Ratan Tata, Chairman, Tata Group in 2011 and Mr. Yash Chopra in...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer